Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 27;16(1):172.
doi: 10.1186/s12978-019-0835-1.

Quality of websites about long-acting reversible contraception: a descriptive cross-sectional study

Affiliations

Quality of websites about long-acting reversible contraception: a descriptive cross-sectional study

Catrin Eriksson et al. Reprod Health. .

Abstract

Background: Today, there are various short- and long-acting contraceptive alternatives available for those who wish to prevent unintended pregnancy. Long-acting reversible contraception are considered effective methods with a high user satisfaction. High-quality information about contraception is essential in order to empower individuals to reach informed decisions based on sufficient knowledge. Use of the Web for information about contraception is widespread, and there is a risk that those who use it for this purpose could come in contact with sources of low quality.

Objective: The overarching aim was to investigate the quality of websites about long-acting reversible contraception.

Methods: Swedish client-oriented websites were identified through searches in Google (n = 46 included websites). Reliability and information about long-acting reversible contraceptive choices were assessed by two assessors with the DISCERN instrument, transparency was analyzed with the Journal of the American Medical Association benchmarks, completeness was assessed with inductive content analysis and readability was analyzed with Readability Index.

Results: The mean DISCERN was 44.1/80 (SD 7.7) for total score, 19.7/40 (SD 3.7) for reliability, 22.1/35 (SD 4.1) for information about long-acting reversible contraceptive choices, and 2.3/5 (SD 1.1) for overall quality. A majority of the included websites had low quality with regard to what sources were used to compile the information (n = 41/46, 89%), when the information was produced (n = 40/46, 87%), and if it provided additional sources of support and information (n = 30/46, 65%). Less than half of the websites adhered to any of the JAMA benchmarks. We identified 23 categories of comprehensiveness. The most frequent was contraceptive mechanism (n = 39/46, 85%) and the least frequent was when contraception may be initiated following an abortion (n = 3/46, 7%). The mean Readability Index was 42.5 (SD 6.3, Range 29-55) indicating moderate to difficult readability levels, corresponding to a grade level of 9.

Conclusions: The quality of client-oriented websites about long-acting reversible contraception is poor. There is an undeniable need to support and guide laypersons that intend to use web-based sources about contraceptive alternatives, so that they may reach informed decisions based on sufficient knowledge.

Keywords: Consumer health information; Long-acting reversible contraception; World wide web.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Search process for websites about long-acting reversible contraception
Fig. 2
Fig. 2
Distributions of DISCERN scores for the included websites (n = 46) about long-acting reversible contraception (LARC), ranging from 1 (no/low quality) to 5 (yes/high quality)

Similar articles

Cited by

References

    1. Committee on Practice Bulletins-Gynecology, Long-acting Reversible Contraception Work Group Practice bulletin no. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017;130:e251–e269. - PubMed
    1. Hubacher D, Spector H, Monteith C, Chen P-L, Hart C. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Am J Obstet Gynecol. 2017;216:101–109. doi: 10.1016/j.ajog.2016.08.033. - DOI - PMC - PubMed
    1. Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105–1113. doi: 10.1097/AOG.0b013e31821188ad. - DOI - PMC - PubMed
    1. National Institute for Health and Care Excellence. Long-acting reversible contraception. 2019 [cited 2019 Feb 24]. Available from: https://www.nice.org.uk/guidance/cg30/resources/longacting-reversible-co.... - PubMed
    1. Swedish Medical Products Agency . Antikonception - behandlingsrekommendation [Contraception - treatment recommendation] 2014.